[新聞] 羅氏將在美國投資500億美元於製藥和診斷

看板Stock (股票)作者TyuzuChou (潤潤潤)時間3小時前 (2025/04/22 13:46)推噓21(21推 0噓 18→)

留言39則, 28人參與討論串1/1

原文標題： Roche to invest USD 50 billion in pharmaceuticals and diagnostics in the United States over the next five years 原文連結：https://tinyurl.com/2h8hnjuv 發布時間：Tue, April 22, 2025 at 1:00 PM GMT+8 記者署名：F. Hoffmann-La Roche Ltd 原文內容： Basel, 22 April 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will invest USD 50 billion into the United States of America in the next five years. These investments further strengthen Roche’s already significant US footprint with 13 manufacturing and 15 R&D sites across the Pharmaceutical and Diagnostics Divisions, and are expected to create more than 12,000 new jobs, including nearly 6,500 construction jobs, as well as 1,000 jobs at new and expanded facilities. As part of this investment, Roche will increase its existing footprint of more than 25,000 employees in 24 sites across eight US states. The investment will include: Expanded and upgraded US manufacturing and distribution capabilities for its innovative medicines and diagnostics portfolio in Kentucky, Indiana, New Jersey, Oregon and California A state-of-the-art gene therapy manufacturing facility in Pennsylvania A new 900,000 square foot manufacturing centre to support Roche’s expanding portfolio of next generation weight loss medicines (location to be announced) A new manufacturing facility for continuous glucose monitoring in Indiana A new R&D centre in Massachusetts, conducting cutting-edge artificial intelligence (AI) research and serving as hub for our new cardiovascular, renal and metabolism research and development efforts Significant expansion and upgrading of our existing pharmaceuticals and diagnostics R&D centres in Arizona, Indiana and California “Roche is a Swiss company with a strong heritage in more than 130 countries globally. Today’s announced investments underscore our long-standing commitment to research, development and manufacturing in the US,” said Thomas Schinecker, Roche Group CEO. “We are proud of our 110 year legacy in the United States which has been a key driver for jobs, innovation and the creation of intellectual property in the US, across both our Pharmaceutical and Diagnostics Divisions. Our investments of USD 50 billion over the next five years will lay the foundation for our next era of innovation and growth, benefiting patients in the US and around the world.” Once all new and expanded manufacturing capacity comes on-line, Roche will export more medicines from the US than it imports. Today, its diagnostics division already has an export surplus from the US to other countries. About Roche Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world’s largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world. We are a pioneer in personalised healthcare and want to further transform how healthcare is delivered to have an even greater impact. To provide the best care for each person we partner with many stakeholders and combine our strengths in Diagnostics and Pharma with data insights from the clinical practice. For over 125 years, sustainability has been an integral part of Roche’s business. As a science-driven company, our greatest contribution to society is developing innovative medicines and diagnostics that help people live healthier lives. Roche is committed to the Science Based Targets initiative and the Sustainable Markets Initiative to achieve net zero by 2045. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com. 心得/評論：羅氏（SIX: RO, ROG; OTCQX: RHHBY）今日宣布，將在未來五年內向美國投資500億美元。這些投資將進一步鞏固羅氏在美國的顯著影響力，該公司目前在美國擁有13個製造基地和15個研發基地，涵蓋製藥和診斷部門，預計將創造超過12,000個新就業機會，包括近6,500個建築工作崗位，以及新擴建設施中的1,000個工作崗位。作為此次投資的一部分，羅氏將擴大其在美國八個州24個地點、超過25,000 名員工的現有規模。投資內容包括：在肯塔基州、印第安納州、新澤西州、俄勒岡州和加利福尼亞州擴展和升級其創新藥物和診斷產品組合的製造和分銷能力在賓夕法尼亞州建立一座先進的基因療法製造設施建立一個90萬平方英尺的新製造中心，以支持羅氏不斷擴展的下一代減重藥物產品組合（地點待公布）在印第安納州建立一座用於連續血糖監測的新製造設施在馬薩諸塞州建立一個新的研發中心，進行尖端人工智能（AI）研究，並作為心血管、腎臟和代謝研究與開發的新中心在亞利桑那州、印第安納州和加利福尼亞州顯著擴展和升級現有的製藥和診斷研發中心羅氏集團首席執行官托馬斯·辛內克（Thomas Schinecker）表示：“羅氏是一家瑞士公司，在全球130多個國家擁有悠久歷史。今天宣布的投資凸顯了我們對美國研發和製造的長期承諾。我們為在美國110年的傳承感到自豪，這一直是美國就業、創新和知識產權創造的關鍵驅動力，涵蓋我們的製藥和診斷部門。未來五年500億美元的投資將為我們的下一階段創新和增長奠定基礎，造福美國及全球的患者。” 一旦所有新建和擴建的製造能力上線，羅氏從美國出口的藥物將超過其進口量。目前，其診斷部門已從美國向其他國家實現出口順差。 *** 丸子川普一定又要臭彈了他又要說他的關稅政策又成功了又一家跨國先進的大公司要到美國投資了 -- ※ 發信站: 批踢踢實業坊(ptt.cc), 來自: 150.117.197.145 (臺灣) ※ 文章網址: https://www.ptt.cc/bbs/Stock/M.1745300794.A.F0F.html

推

tony15899

04/22 13:47, 3小時前 , 1^F

04/22 13:47, 1^F

※ 編輯: TyuzuChou (150.117.197.145 臺灣), 04/22/2025 13:48:48

推

victorru

04/22 13:48, 3小時前 , 2^F

04/22 13:48, 2^F

推

jei01

04/22 13:49, 3小時前 , 3^F